Virtual reality offers new hope for vision loss after childhood brain tumors

NCT ID NCT07558395

First seen May 01, 2026 · Last updated May 01, 2026

Summary

This study tests a home-based virtual reality program designed to improve visual perception in children, teens, and young adults who have hemianopsia (loss of half their visual field) due to a past brain tumor. About 120 participants will use audiovisual stimulation in VR for 8 weeks. The goal is to see if this training can expand their usable vision and improve daily life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Paediatric and adolescents medicine, Medical University

    Vienna, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Great Ormond Street Hospital for Children

    London, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpital de Hautepierre

    Strasbourg, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Institute of Tumour, department of haematology and Oncohaematology paediatric

    Milan, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Paediatric Haematology, University Hospital

    Padova, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Paediatric Oncology, San Joan de Deu

    Barcelona, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Paediatrics and Adolescents Medicine, University Hospital

    Copenhagen, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Princess Maxima Centre for Paediatric Oncology

    Utrecht, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.